-
ESMO Hot Topic Express | Updated Results on Patient Outcomes, Drug Exposure, Safety, and Quality of Life Relevance in the TALAPRO-2 Study
In recent years, there have been groundbreaking advancements in the exploration of treatment modalities for prostate cancer, particularly in the use of PARP inhibitors in combination with novel hormonal therapies, offering new hope for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The TALAPRO-2 study has demonstrated that the combination of talazoparib with enzalutamide significantly…
-
ESMO 5-Minute Insights | DXd ADCs Shine at ESMO: Professor Jian Zhang Introduces Research in the Field of Breast Cancer
ADC drugs, also known as Antibody-Drug Conjugates, combine targeted antibodies with cytotoxic drugs to accurately attack tumor cells and minimize damage to normal cells. In recent years, ADC drugs have made significant breakthroughs in the field of cancer treatment and have become a focus of attention. At this year’s ESMO conference, several studies on ADC…
-
The ESMO Congress 2023 has Successfully Concluded, and Ten Major Research Projects Have Bloomed at the Conference!
The ESMO Congress 2023, held from October 20th to 24th in Madrid, Spain, has concluded, marking a significant milestone in the field of oncology. With a central theme of “Disseminating innovative research for optimal cancer care,” this year’s event featured a unique blend of in-person and virtual components, uniting cancer researchers, clinicians, and experts from…
-
Dr. Chun-rong Ju: Lung Transplant Recipients Receive Prolonged Contezolid Treatment for Nocardia InfectionDr. Chun-rong Ju: Lung Transplant Recipients
Nocardia is a conditional pathogen, and infections are common in immunocompromised populations such as organ transplant recipients. Professor Chunrong Ju and her team at the First Affiliated Hospital of Guangzhou Medical University’s Respiratory and Critical Care Department and Transplant Department previously reported cases of Nocardia infection in lung transplant recipients (LTR) among the East Asian…
-
Dr. Ryan J. Sullivan: When does targeted therapy outperform immunotherapy in patients with advanced melanoma?
The landscape of advanced melanoma treatment has witnessed a remarkable transformation with the introduction of targeted therapies and immunotherapies. While immunotherapy has shown great promise in various cancer types, there…
-
ESMO Hot Review | Professors Lu Si and LiLi Mao: Addressing Challenges in the Treatment of Melanoma, Breaking Through the Difficulties of Brain Metastases
Editor’s Note: The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place in Madrid, Spain as scheduled. What new developments are there in the field of melanoma, which…
-
IDWeek Highlights | Dr. Hong-mei Xu: Consistency Evaluation of Congenital CMV Infection in Dried Blood Spots and Plasma PCR Testing
Editor’s Note: Newborns can be infected with congenital cytomegalovirus (CMV) through vertical mother-to-child transmission, and CMV infection screening is required for some newborns with specific indications. Polymerase chain reaction (PCR)…
-
Dr. Chun-rong Ju: Lung Transplant Recipients Receive Prolonged Contezolid Treatment for Nocardia Infection
Editor’s note: Nocardia is a conditional pathogen, and infections are common in immunocompromised populations such as organ transplant recipients. Professor Chunrong Ju and her team at the First Affiliated Hospital…
Connecting Medical Expertise through Media